ROBIN CHAR: Open Payments
NPI 1588248637 · KAMUELA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$104 in 4 payments from 3 companies in 2025. Trend: 2023 $67 · 2024 $164 · 2025 $104
Food & beverage: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $21 |
Products named: VRAYLAR, ABILIFY ASIMTUFII, Ozempic.
Industry payments across HI — which companies pay providers there.
